![](/img/cover-not-exists.png)
The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer
Inglis, Daniel J, Lavranos, Tina C, Beaumont, Donna M, Leske, Annabell F, Brown, Chloe K, Hall, Allison J, Kremmidiotis, GabrielVolume:
15
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/15384047.2014.956605
Date:
November, 2014
File:
PDF, 649 KB
english, 2014